Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF versus azathioprine monotherapy for prevention of chronic allograft nephropathy after kidney transplantation
2006-005604-14Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Chronic Allograft Kidney Disease (CKaD) and kidney allograft rejection comparing Mycophenolate mofetil monotherapy with Azathioprine monotherapy (2 arms). Primary endpoint: Incidence of biopsy-proven chronic allograft nephropathy. Started Jan 2007; status: completed.
02
Drugs
mycophenolate mofetilazathioprine
03
Conditions
Chronic Allograft Kidney Disease (CKaD)kidney allograft rejection
Beyond the preview
Go deeper on 2006-005604-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005604-14.